CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung ....
Phase 2
Montreal, Quebec, Canada and 9 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Montreal, Canada and 84 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Montreal, Quebec, Canada and 210 other locations
This is a phase III randomized open label study designed to compare JDQ443 as monotherapy to docetaxel in participants with advanced non-small...
Phase 3
Montreal, Quebec, Canada and 52 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Montreal, Quebec, Canada and 230 other locations
in subjects with locally advanced and unresectable or metastatic non-small cell lung cancer with a KRAS ...
Phase 1
Montreal, Quebec, Canada and 30 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
Montreal, Quebec, Canada and 299 other locations
Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI...
Phase 3
Montreal, Quebec, Canada and 206 other locations
This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...
Phase 2
Greenfield Park, Quebec, Canada and 254 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Montreal, Quebec, Canada and 97 other locations
Clinical trials
Research sites
Resources
Legal